Clearline Capital’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-49,885
Closed -$820K 120
2026
Q1
$820K Sell
49,885
-266,971
-84% -$6.56M 0.04% 99
2025
Q4
$9.05M Buy
316,856
+84,283
+36% +$2.28M 0.45% 44
2025
Q3
$6.85M Sell
232,573
-7,963
-3% -$218K 0.31% 65
2025
Q2
$6.93M Buy
240,536
+119,170
+98% +$3.52M 0.26% 55
2025
Q1
$4.24M Buy
121,366
+6,219
+5% +$254K 0.26% 66
2024
Q4
$5.13M Sell
115,147
-197,853
-63% -$8.09M 0.68% 47
2024
Q3
$14.3M Buy
313,000
+6,300
+2% +$255K 0.61% 27
2024
Q2
$10.2M Sell
306,700
-285,683
-48% -$11.7M 0.28% 39
2024
Q1
$28.4M Buy
592,383
+298,009
+101% +$17.4M 1.39% 10
2023
Q4
$21.7M Buy
294,374
+55,041
+23% +$3.72M 1.33% 12
2023
Q3
$17.5M Buy
239,333
+116,234
+94% +$9.28M 1.5% 18
2023
Q2
$10.2M Sell
123,099
-7,148
-5% -$626K 0.59% 25
2023
Q1
$11.6M Buy
130,247
+68,720
+112% +$5.98M 1.75% 17
2022
Q4
$5.27M Buy
+61,527
New +$5.21M 0.94% 35

Other funds holding QDEL

Clearline Capital's QDEL Position: Q2 2026 in Review

Clearline Capital sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 49,885 shares — an estimated $820K sold.

Clearline Capital first reported a position in QDEL in Q4 2022 and held it in 14 quarters. The position peaked at $28.4M in Q1 2024. 246 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Clearline Capital reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
  • Clearline Capital sold 49,885 QuidelOrtho shares in Q2 2026, an estimated $820K.
  • Clearline Capital first reported a position in QuidelOrtho in Q4 2022 and held it in 14 quarters.
  • Clearline Capital's QuidelOrtho position peaked at $28.4M in Q1 2024.
  • 246 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Clearline Capital's 13F filing for Q2 2026, filed 14 Aug 2026.